Literature DB >> 8645341

Inhibition of proliferation but not erythroid differentiation of J2E cells by rapamycin.

R Jaster1, T Bittorf, S P Klinken, J Brock.   

Abstract

During erythropoiesis, replication and maturation are tightly coupled processes. Here, we show that the immunosuppressant rapamycin inhibited basal- as well as erythropoietin-stimulated proliferation of the erythroid cell line J2E. In addition, it enhanced the antiproliferative effect of sodium butyrate. Although rapamycin suppressed erythroid cell division, it did not affect terminal differentiation induced by erythropoietin or sodium butyrate. The proliferative status of J2E cells correlated well with the activity of the ribosomal S6 kinase p70S6k, an enzyme effectively blocked by rapamycin. It was concluded from this study that erythroid maturation proceeded normally despite the rapamycin-induced inhibition of mitosis and of p70S6k activity. These data provide further evidence that separate signalling pathways for proliferation and differentiation exist in erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645341     DOI: 10.1016/0006-2952(96)00044-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Diagnostic application of the A(1c) assay in renal disease.

Authors:  Adnan Sharif; Keshwar Baboolal
Journal:  J Am Soc Nephrol       Date:  2010-02-04       Impact factor: 10.121

2.  Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects.

Authors:  Sofia Sofroniadou; David Goldsmith
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

3.  Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipients.

Authors:  Jean-Baptiste Woillard; Nassim Kamar; Annick Rousseau; Lionel Rostaing; Pierre Marquet; Nicolas Picard
Journal:  Pharmacogenet Genomics       Date:  2012-10       Impact factor: 2.089

4.  Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus.

Authors:  A A M Ali; P Khanna; A Mehrotra; G Abraham
Journal:  Indian J Nephrol       Date:  2011-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.